Blueprint Medicines Corp Quarterly Common Stock, Shares, Outstanding from Q4 2014 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Blueprint Medicines Corp quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2014 to Q3 2024.
  • Blueprint Medicines Corp Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 63.5M shares, a 4.47% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 63.5M +2.71M +4.47% Sep 30, 2024 10-Q 2024-10-30
Q2 2024 63.2M +2.53M +4.17% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 62.6M +2.18M +3.61% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 61.1M +1.19M +1.98% Dec 31, 2023 10-Q 2024-10-30
Q3 2023 60.7M +932K +1.56% Sep 30, 2023 10-Q 2023-10-26
Q2 2023 60.6M +950K +1.59% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 60.4M +860K +1.45% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 60M +818K +1.38% Dec 31, 2022 10-K 2024-02-15
Q3 2022 59.8M +2.01M +3.49% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 59.7M +1.13M +1.94% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 59.6M +1.28M +2.19% Mar 31, 2022 10-Q 2022-05-03
Q4 2021 59.1M +1.35M +2.33% Dec 31, 2021 10-K 2023-02-16
Q3 2021 57.8M +3.28M +6.02% Sep 30, 2021 10-Q 2021-10-28
Q2 2021 58.6M +4.27M +7.87% Jun 30, 2021 10-Q 2021-07-29
Q1 2021 58.3M +4.11M +7.59% Mar 31, 2021 10-Q 2021-04-29
Q4 2020 57.8M +8.52M +17.3% Dec 31, 2020 10-K 2022-02-17
Q3 2020 54.5M +5.34M +10.9% Sep 30, 2020 10-Q 2020-10-29
Q2 2020 54.3M +5.22M +10.7% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 54.2M +10M +22.6% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 49.3M +5.24M +11.9% Dec 31, 2019 10-K 2021-02-17
Q3 2019 49.2M +5.23M +11.9% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 49.1M +5.18M +11.8% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 44.2M +350K +0.8% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 44M +460K +1.05% Dec 31, 2018 10-K 2020-02-13
Q3 2018 43.9M +4.77M +12.2% Sep 30, 2018 10-Q 2018-10-30
Q2 2018 43.9M +4.8M +12.3% Jun 30, 2018 10-Q 2018-08-01
Q1 2018 43.8M +10.6M +31.8% Mar 31, 2018 10-Q 2018-05-02
Q4 2017 43.6M +10.5M +31.6% Dec 31, 2017 10-K 2019-02-26
Q3 2017 39.2M +11.9M +43.5% Sep 30, 2017 10-Q 2017-10-31
Q2 2017 39.1M +11.9M +43.5% Jun 30, 2017 10-Q 2017-08-02
Q1 2017 33.2M +6.11M +22.5% Mar 31, 2017 10-Q 2017-05-03
Q4 2016 33.1M +6.06M +22.4% Dec 31, 2016 10-K 2018-02-21
Q3 2016 27.3M +398K +1.48% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 27.2M +535K +2.01% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 27.1M +25.4M +1468% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 27.1M +25.4M +1564% Dec 31, 2015 10-K 2017-03-09
Q3 2015 26.9M Sep 30, 2015 10-Q 2015-11-09
Q2 2015 26.7M Jun 30, 2015 10-Q 2015-08-10
Q1 2015 1.73M Mar 31, 2015 10-Q 2015-06-11
Q4 2014 1.63M Dec 31, 2014 10-K 2016-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.